AR009338A1 - MULTIVITAMINIC UNIT DOSE COMPOSITION AND USES OF SUCH DOSE COMPOSITION - Google Patents
MULTIVITAMINIC UNIT DOSE COMPOSITION AND USES OF SUCH DOSE COMPOSITIONInfo
- Publication number
- AR009338A1 AR009338A1 ARP970103874A AR009338A1 AR 009338 A1 AR009338 A1 AR 009338A1 AR P970103874 A ARP970103874 A AR P970103874A AR 009338 A1 AR009338 A1 AR 009338A1
- Authority
- AR
- Argentina
- Prior art keywords
- vitamin
- dose composition
- unit dose
- multivitaminic
- composition
- Prior art date
Links
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 abstract 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 abstract 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 abstract 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 abstract 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 abstract 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 abstract 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 abstract 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 abstract 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 abstract 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 abstract 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 abstract 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 abstract 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 abstract 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 abstract 1
- 229930003451 Vitamin B1 Natural products 0.000 abstract 1
- 229930003779 Vitamin B12 Natural products 0.000 abstract 1
- 229930003471 Vitamin B2 Natural products 0.000 abstract 1
- 229930003571 Vitamin B5 Natural products 0.000 abstract 1
- 229930003268 Vitamin C Natural products 0.000 abstract 1
- 229930003316 Vitamin D Natural products 0.000 abstract 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 abstract 1
- 229930003427 Vitamin E Natural products 0.000 abstract 1
- 229930003448 Vitamin K Natural products 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 abstract 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 abstract 1
- 235000013734 beta-carotene Nutrition 0.000 abstract 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 abstract 1
- 239000011648 beta-carotene Substances 0.000 abstract 1
- 229960002747 betacarotene Drugs 0.000 abstract 1
- 229960002685 biotin Drugs 0.000 abstract 1
- 235000020958 biotin Nutrition 0.000 abstract 1
- 239000011616 biotin Substances 0.000 abstract 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 abstract 1
- 229960002079 calcium pantothenate Drugs 0.000 abstract 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 abstract 1
- 229960001231 choline Drugs 0.000 abstract 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 abstract 1
- 229960000304 folic acid Drugs 0.000 abstract 1
- 235000019152 folic acid Nutrition 0.000 abstract 1
- 239000011724 folic acid Substances 0.000 abstract 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 abstract 1
- 229960000367 inositol Drugs 0.000 abstract 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 229960003966 nicotinamide Drugs 0.000 abstract 1
- 235000005152 nicotinamide Nutrition 0.000 abstract 1
- 239000011570 nicotinamide Substances 0.000 abstract 1
- 229960003512 nicotinic acid Drugs 0.000 abstract 1
- 235000001968 nicotinic acid Nutrition 0.000 abstract 1
- 239000011664 nicotinic acid Substances 0.000 abstract 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 abstract 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 abstract 1
- 229960002477 riboflavin Drugs 0.000 abstract 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 abstract 1
- 229960003495 thiamine Drugs 0.000 abstract 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 abstract 1
- 229940088594 vitamin Drugs 0.000 abstract 1
- 229930003231 vitamin Natural products 0.000 abstract 1
- 235000013343 vitamin Nutrition 0.000 abstract 1
- 239000011782 vitamin Substances 0.000 abstract 1
- 235000019155 vitamin A Nutrition 0.000 abstract 1
- 239000011719 vitamin A Substances 0.000 abstract 1
- 235000010374 vitamin B1 Nutrition 0.000 abstract 1
- 239000011691 vitamin B1 Substances 0.000 abstract 1
- 235000019163 vitamin B12 Nutrition 0.000 abstract 1
- 239000011715 vitamin B12 Substances 0.000 abstract 1
- 235000019164 vitamin B2 Nutrition 0.000 abstract 1
- 239000011716 vitamin B2 Substances 0.000 abstract 1
- 235000009492 vitamin B5 Nutrition 0.000 abstract 1
- 239000011675 vitamin B5 Substances 0.000 abstract 1
- 235000019158 vitamin B6 Nutrition 0.000 abstract 1
- 239000011726 vitamin B6 Substances 0.000 abstract 1
- 235000019154 vitamin C Nutrition 0.000 abstract 1
- 239000011718 vitamin C Substances 0.000 abstract 1
- 235000019166 vitamin D Nutrition 0.000 abstract 1
- 239000011710 vitamin D Substances 0.000 abstract 1
- 150000003710 vitamin D derivatives Chemical class 0.000 abstract 1
- 235000019165 vitamin E Nutrition 0.000 abstract 1
- 239000011709 vitamin E Substances 0.000 abstract 1
- 229940046009 vitamin E Drugs 0.000 abstract 1
- 235000019168 vitamin K Nutrition 0.000 abstract 1
- 239000011712 vitamin K Substances 0.000 abstract 1
- 150000003721 vitamin K derivatives Chemical class 0.000 abstract 1
- 229940045997 vitamin a Drugs 0.000 abstract 1
- 229940011671 vitamin b6 Drugs 0.000 abstract 1
- 229940046008 vitamin d Drugs 0.000 abstract 1
- 229940046010 vitamin k Drugs 0.000 abstract 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Una composicion de dosis de unidad multivitamínica que comprende: Vitamina A: 1500 IU; Vitamina B1: 6 mg; Vitamina B2: 6 mg; Niacina: 10 mg; Niacinamida:30 mg; Vitamina B5: 45 mg; Vitamina B6: 6 mg; Vitamina B12: 90 mcg; Biotina: 21 mcg; Acido Parabenzoico: 35 mg; Vitamina C: 50 mg; Vitamina D: 25 IU; VitaminaE di alfa: 50 IU; Vitamina K: 0,5 mg; Acido folico: 125 mcg; Inositol: 10 mg; Colino: 35 mg; Caroteno beta: 825 IU; bioflavoroida: 75 mg. La composicionse usa para la fabricacion de unacomposicion de dosis de unidad multivitamínica que provee vitaminas a una persona con necesidad de ellas.A multivitamin unit dose composition comprising: Vitamin A: 1500 IU; Vitamin B1: 6 mg; Vitamin B2: 6 mg; Niacin: 10mg; Niacinamide: 30mg; Vitamin B5: 45 mg; Vitamin B6: 6 mg; Vitamin B12: 90 mcg; Biotin: 21 mcg; Parabenzoic Acid: 35 mg; Vitamin C: 50 mg; Vitamin D: 25 IU; Vitamin E di alpha: 50 IU; Vitamin K: 0.5 mg; Folic acid: 125 mcg; Inositol: 10 mg; Choline: 35 mg; Beta carotene: 825 IU; bioflavoroide: 75 mg. The composition is used for the manufacture of a multivitamin unit dose composition that provides vitamins to a person in need of them.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US70330196A | 1996-08-26 | 1996-08-26 | |
| US74455096A | 1996-11-06 | 1996-11-06 | |
| US83336597A | 1997-04-04 | 1997-04-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR009338A1 true AR009338A1 (en) | 2000-04-12 |
Family
ID=27418756
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP970103874 AR009338A1 (en) | 1996-08-26 | 1997-08-26 | MULTIVITAMINIC UNIT DOSE COMPOSITION AND USES OF SUCH DOSE COMPOSITION |
Country Status (6)
| Country | Link |
|---|---|
| AR (1) | AR009338A1 (en) |
| AU (1) | AU4162297A (en) |
| CO (1) | CO4900029A1 (en) |
| ID (1) | ID19355A (en) |
| MA (1) | MA24308A1 (en) |
| WO (1) | WO1998008522A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7951844B2 (en) | 2007-04-05 | 2011-05-31 | J-Oil Mills, Inc. | Tranquilizer and functional food |
| CN104027339B (en) * | 2014-06-12 | 2017-01-18 | 王淑芳 | Vitamin composition and application thereof in regulating ovarian function |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4432975A (en) * | 1981-04-13 | 1984-02-21 | Icn Pharmaceuticals, Inc. | Process for introducing vitamin B-12 into the bloodstream |
| US4945083A (en) * | 1986-06-03 | 1990-07-31 | Jansen Jr Christian J | Safe oral folic-acid-containing vitamin preparation |
| US5308627A (en) * | 1990-08-07 | 1994-05-03 | Umbdenstock Jr Anthony J | Nutritional supplement for optimizing cellular health |
| US5514382A (en) * | 1994-10-17 | 1996-05-07 | Sultenfuss; Sherry | Daily vitamin and mineral supplement for women |
-
1997
- 1997-08-25 CO CO97048862A patent/CO4900029A1/en unknown
- 1997-08-26 AR ARP970103874 patent/AR009338A1/en unknown
- 1997-08-26 ID IDP972975A patent/ID19355A/en unknown
- 1997-08-26 AU AU41622/97A patent/AU4162297A/en not_active Abandoned
- 1997-08-26 WO PCT/US1997/014968 patent/WO1998008522A1/en not_active Ceased
- 1997-08-26 MA MA24777A patent/MA24308A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU4162297A (en) | 1998-03-19 |
| WO1998008522A1 (en) | 1998-03-05 |
| ID19355A (en) | 1998-07-02 |
| CO4900029A1 (en) | 2000-03-27 |
| MA24308A1 (en) | 1998-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5770215A (en) | Multivitamin/vascular occlusion inhibiting composition | |
| DE69332777D1 (en) | MULTIVITAMIN AND MINERAL SUPPLEMENT FOR PREGNANT | |
| ES2269514T5 (en) | Nutritive compound to treat immune conditions | |
| AR004108A1 (en) | USE OF 4- (4-FLUOROBENCILAMINO) -2-AMINO-1-ETOXICARBONYLAMINOBENZENE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR THE PREPARATION OF A MEDICINAL PRODUCT INTENDED FOR THE PROPHYLAXIS AND SANTA CRUISE OF ACUTE INSUFFICIENCY AND CRANE LAUR THE TREATMENT OF NEURODEGENRATIVE DISEASES | |
| Russell | New views on the RDAs for older adults | |
| BR0114080A (en) | Dietary supplement, use thereof, method to assist in the prevention or treatment of oxidative damage, food, and methods for manufacturing the same, and to improve or increase the work output of an animal. | |
| MX9301787A (en) | NUTRITIONAL LIQUID PRODUCT FOR ENTERAL FEEDING. | |
| NZ516101A (en) | Pharmaceutical and nutritional compositions containing essential fatty acids and homocysteine-lowering agents | |
| MX9307884A (en) | APPLICATION OF CARBAMAZEPINE OR OXCARBAMAZEPINE FOR THE PREPARATION OF MEDICINES FOR THE TREATMENT OF NEUROLOGICAL INJURIES LINKED TO TRAUMATISMS. | |
| US10617700B1 (en) | Vitamin supplement compositions with enhanced bioavailability | |
| CY1112547T1 (en) | Means Containing Folic Acid, Vitamin B6 And Vitamin B12, And Their Use | |
| ES2092275T3 (en) | NUTRITIVE PRODUCT FOR PEOPLE WHO RECEIVE KIDNEY DIALYSIS. | |
| ES2185816T3 (en) | FORMS OF PHARMACEUTICAL DOSAGE FOR THE ORAL ROUTE, WHICH INCLUDE AN INHIBITING AGENT OF THE PUMP OF PROTONS AND A PROCEDURAL AGENT. | |
| AR042262A2 (en) | USE OF 8,9-DIHYDROESTRONE FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF ATEROSCLEROSIS | |
| AR013175A1 (en) | USE OF LACTIC ACID BACTERIA TO PREPARE AN ORAL COMPOSITION FOR MAMMALS USEFUL TO FACILITATE ABSORPTION | |
| WO2002047493A3 (en) | Health promoting compositions | |
| BR9609413A (en) | Dietary and pharmaceutical formulations for the prophylaxis and treatment of gastrointestinal disorders | |
| GB2254556A (en) | Linolenic acid formulations | |
| WO1995031991A3 (en) | Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases | |
| CO2023004351A2 (en) | Biofactors for the treatment and prophylaxis of dementia | |
| AR009338A1 (en) | MULTIVITAMINIC UNIT DOSE COMPOSITION AND USES OF SUCH DOSE COMPOSITION | |
| AR026254A1 (en) | THE USE OF A CONTROLLED RELEASE PREPARATION FOR THE PREPARATION OF A MEDICINAL PRODUCT TO INCREASE THE DOSE OR SYSTEM EXPOSURE OF A PHARMACO THAT INHIBITS PHOSPHODESTERASE 4 | |
| IT1254045B (en) | WATER SOLUBLE DERIVATIVES OF BIOTIN AND RELATED THERAPEUTIC COMPOSITIONS | |
| CL2004000813A1 (en) | PHARMACEUTICAL OR DIETETIC COMPOSITION THAT INCLUDES VITAMINS, MINERALS, OLIGOELEMENTS, DOCOSAHEXANOIC ACID (DHA) AND AN APPROPRIATE VEHICLE, ITS USE AND METHOD TO SUPPLEMENT THE DIETETIC NEEDS OF A WOMAN WHO IS BREASTFEEDING | |
| ES2058909T3 (en) | AGENT FOR THE CARE OF NAILS, SKIN AND HAIR. |